Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
3.020
-0.070 (-2.27%)
Dec 20, 2024, 4:00 PM EST - Market closed
Kazia Therapeutics Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Operating Revenue | 2.31 | 2.31 | - | - | 15.18 | - | Upgrade
|
| Other Revenue | 0.17 | 0.17 | 0 | 0.01 | - | 0.99 | Upgrade
|
| Revenue | 2.48 | 2.48 | 0 | 0.01 | 15.18 | 0.99 | Upgrade
|
| Revenue Growth (YoY) | 248000.00% | 248000.00% | -90.00% | -99.93% | 1436.54% | -31.38% | Upgrade
|
| Gross Profit | 2.48 | 2.48 | 0 | 0.01 | 15.18 | 0.99 | Upgrade
|
| Selling, General & Admin | 13.56 | 13.56 | 8.58 | 5.24 | 7.02 | 3.69 | Upgrade
|
| Research & Development | 17.38 | 17.38 | 15.56 | 20.17 | 14.54 | 9.49 | Upgrade
|
| Other Operating Expenses | - | - | - | -0.02 | -0 | -0 | Upgrade
|
| Operating Expenses | 30.94 | 30.94 | 24.15 | 25.39 | 21.56 | 13.18 | Upgrade
|
| Operating Income | -28.46 | -28.46 | -24.15 | -25.38 | -6.38 | -12.19 | Upgrade
|
| Interest & Investment Income | 0.01 | 0.01 | 0.02 | 0 | 0.04 | 0.07 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | - | - | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.28 | 1.28 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -27.17 | -27.17 | -24.12 | -25.38 | -6.34 | -12.12 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | - | -0.17 | Upgrade
|
| Other Unusual Items | 0.12 | 0.12 | 3.39 | - | -2.57 | -0.47 | Upgrade
|
| Pretax Income | -27.05 | -27.05 | -20.74 | -25.38 | -8.91 | -12.77 | Upgrade
|
| Income Tax Expense | -0.27 | -0.27 | -0.27 | -0.37 | -0.48 | -0.3 | Upgrade
|
| Earnings From Continuing Operations | -26.78 | -26.78 | -20.47 | -25.01 | -8.42 | -12.47 | Upgrade
|
| Net Income | -26.78 | -26.78 | -20.47 | -25.01 | -8.42 | -12.47 | Upgrade
|
| Net Income to Common | -26.78 | -26.78 | -20.47 | -25.01 | -8.42 | -12.47 | Upgrade
|
| Shares Outstanding (Basic) | 3 | 3 | 2 | 1 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 3 | 3 | 2 | 1 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | 43.08% | 43.08% | 39.12% | 12.57% | 61.08% | 27.04% | Upgrade
|
| EPS (Basic) | -10.16 | -10.16 | -11.11 | -18.88 | -7.16 | -17.07 | Upgrade
|
| EPS (Diluted) | -10.16 | -10.16 | -11.11 | -18.88 | -7.16 | -17.07 | Upgrade
|
| Free Cash Flow | -9.58 | -9.58 | -15.16 | -22.76 | -9.11 | -8.81 | Upgrade
|
| Free Cash Flow Per Share | -3.63 | -3.63 | -8.22 | -17.18 | -7.74 | -12.06 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -1147.20% | -1147.20% | -2414600.00% | -253840.00% | -42.01% | -1234.06% | Upgrade
|
| Profit Margin | -1079.32% | -1079.32% | -2046500.00% | -250140.00% | -55.47% | -1261.75% | Upgrade
|
| Free Cash Flow Margin | -386.17% | -386.17% | -1515600.00% | -227620.00% | -60.01% | -891.55% | Upgrade
|
| EBITDA | -26.59 | -26.59 | -22.28 | -23.52 | -5.11 | -11.11 | Upgrade
|
| EBITDA Margin | - | - | - | - | -33.68% | - | Upgrade
|
| D&A For EBITDA | 1.87 | 1.87 | 1.87 | 1.87 | 1.27 | 1.08 | Upgrade
|
| EBIT | -28.46 | -28.46 | -24.15 | -25.38 | -6.38 | -12.19 | Upgrade
|
| EBIT Margin | - | - | - | - | -42.01% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.